Skip to main content

Catecholaminergic Enzymes in Parkinson’s Disease and Related Extrapyramidal Diseases

  • Chapter
Transmitter Biochemistry of Human Brain Tissue

Abstract

The observation on the decrease in dopamine(Ehringer and Hornykiewicz, 1960) and in aromatic L-amino acid decarboxylase activity with DOPA as a substrate (DOPA decarboxylase activity) (Lloyd and Hornykiewicz, 1970) in the dopaminergic regions of the parkinsonian brain indicated the disturbance in dopamine biosynthesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ehringer, H. and Hornykiewicz, O. (1960). Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) in Gehirn des Menschen und ihr Verhalten bei Erkrankungen des Extrapyramidalen Systems. Klin. Wochenschr., 38 1236–1239.

    Article  Google Scholar 

  • Kato, T., Wakui, Y., Nagatsu, T., and Ohnishi, T. (1978). An improved dual-wavelength spectrophotometric assay for dopamine-β-hydroxylase. Biochem. Pharmacol., 27, 829–831.

    Article  Google Scholar 

  • Lloyd, K. G., Davidson, L. and Hornykiewicz, O. (1975). The neurochemistry of Parkinson’s disease: effect of L-DOPA therapy. J. Pharmacol. Exp. Therap., 195, 453–464.

    Google Scholar 

  • Lloyd, K. and Hornykiewicz, O. (1970). Parkinson’s disease: activity of L-DOPA decarboxylase in discrete brain regions. Science, 170, 1212–1213.

    Article  Google Scholar 

  • McGeer, P. L. and McGeer, E. G. (1976). Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson’s disease and Huntington’s chorea. J. Neurochem., 6, 65–76.

    Google Scholar 

  • Nagatsu, T., Kato, T., Numata(Sudo), Y., Ikuta, K., Sano, M., Nagatsu, I., Kondo, Y., Inagaki, S., Iizuka, R., Hori, A., and Narabayashi, H. (1977). Phenylethanolamine-N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin. Chim. Acta, 75, 221–232.

    Article  Google Scholar 

  • Nagatsu, T., Kato, T., Nagatsu, I., Kondo, Y., Inagaki, S., Iizuka, R., and Narabayashi, H. (1979a). Catecholamine-related enzymes in the brain of patients with parkinsonism and Wilson’s disease. Adv. Neurol., 24, 283–292.

    Google Scholar 

  • Nagatsu, T., Oka, K., and Kato, T. (1979b). Highly sensitive assay for tyrosine hydroxylase activity by high-performance luguid chromatography. J. Chromatogr., 163, 247–252.

    Article  Google Scholar 

  • Nagatsu, T., Yamamoto, T., and Kato, T. (1979c). A new and highly sensitive voltammetric assay for aromatic L-amino acid decarboxylase activity by high-performance liquid chormatogrpahy. Anal. Biochem., 100 160–165.

    Article  Google Scholar 

  • Riederer, P., Rausch, W. -D., Birkmayer, W., Jellinger, K., and Seemann, D. (1978). CNS modulation of adrenal tyrosine hydroxylase in Parkinson’s disease and metabolic encephalopathies. J. Neural Transmission, Suppl., 14, 121–131.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1981 The Contributors

About this chapter

Cite this chapter

Nagatsu, T. et al. (1981). Catecholaminergic Enzymes in Parkinson’s Disease and Related Extrapyramidal Diseases. In: Riederer, P., Usdin, E. (eds) Transmitter Biochemistry of Human Brain Tissue. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05932-4_21

Download citation

Publish with us

Policies and ethics